ALFA Filings
Every announcement, straight from the exchange
Every Eris Lifesciences financial results announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Eris Lifesciences Ltd reported revenue from operations of ₹892.4 Cr (+12.6% YoY) and net profit of ₹187.1 Cr (+39.1% YoY) for Q2 FY27.
Eris Lifesciences Ltd reported revenue from operations of ₹873.2 Cr (+13.0% YoY) and net profit of ₹143.3 Cr (+14.5% YoY) for Q1 FY27.
Eris Lifesciences Ltd reported revenue from operations of ₹756.6 Cr (+7.3% YoY) and net profit of ₹279.1 Cr (+172.8% YoY) for Q4 FY26.
Eris Lifesciences reported audited FY26 results and declared an interim dividend of Rs. 7.21 per share. The company recorded consolidated annual net profit of ₹647.51 Crore.
Eris Lifesciences Ltd reported net profit of ₹109 Cr (+25.1% YoY) for Q3 FY26.